NDC 42549-537

NDC 42549-537

NDC 42549-537 is a in the category. It is labeled and distributed by .

Proprietary NameNDC 42549-537
Marketing Category/

Packaging

NDC SPL Data Element Entries

NDC 42549-537-28 [42549053728]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

NDC 42549-537-60 [42549053760]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

NDC 42549-537-56 [42549053756]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

NDC 42549-537-02 [42549053702]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

NDC 42549-537-30 [42549053730]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

NDC 42549-537-90 [42549053790]

GABAPENTIN TABLET
Marketing CategoryANDA
Application NumberANDA076017
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2009-06-09
Inactivation Date2019-11-13

Drug Details

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.